company background image
MVP logo

Medical Developments International CHIA:MVP Stock Report

Last Price

AU$0.42

Market Cap

AU$47.3m

7D

-3.4%

1Y

-46.7%

Updated

24 Nov, 2024

Data

Company Financials +

Medical Developments International Limited

CHIA:MVP Stock Report

Market Cap: AU$47.3m

MVP Stock Overview

Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. More details

MVP fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Medical Developments International Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medical Developments International
Historical stock prices
Current Share PriceAU$0.42
52 Week HighAU$1.08
52 Week LowAU$0.38
Beta1.53
11 Month Change-10.64%
3 Month Change-8.70%
1 Year Change-46.67%
33 Year Change-91.33%
5 Year Change-93.86%
Change since IPO-65.57%

Recent News & Updates

Recent updates

Shareholder Returns

MVPAU PharmaceuticalsAU Market
7D-3.4%-16.4%0.9%
1Y-46.7%32.3%18.4%

Return vs Industry: MVP underperformed the Australian Pharmaceuticals industry which returned 32.2% over the past year.

Return vs Market: MVP underperformed the Australian Market which returned 18.4% over the past year.

Price Volatility

Is MVP's price volatile compared to industry and market?
MVP volatility
MVP Average Weekly Movement5.3%
Pharmaceuticals Industry Average Movement11.9%
Market Average Movement8.5%
10% most volatile stocks in AU Market17.5%
10% least volatile stocks in AU Market3.2%

Stable Share Price: MVP has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: MVP's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1972n/aBrent MacGregormedicaldev.com

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures.

Medical Developments International Limited Fundamentals Summary

How do Medical Developments International's earnings and revenue compare to its market cap?
MVP fundamental statistics
Market capAU$47.32m
Earnings (TTM)-AU$40.99m
Revenue (TTM)AU$33.15m

1.4x

P/S Ratio

-1.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MVP income statement (TTM)
RevenueAU$33.15m
Cost of RevenueAU$8.78m
Gross ProfitAU$24.37m
Other ExpensesAU$65.36m
Earnings-AU$40.99m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.36
Gross Margin73.50%
Net Profit Margin-123.66%
Debt/Equity Ratio0%

How did MVP perform over the long term?

See historical performance and comparison